Therapeutic agent for neurodegenerative disease
US12268729B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Inventor
Key dates
| Filing date | Sep 30, 2019 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Mar 1, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an agent for the treatment or prophylaxis of a neurodegenerative disease, containing an apoptosis inhibitor of macrophage (AIM), an AIM fragment having a biological activity of AIM, or a nucleic acid encoding the AIM or AIM fragment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.